US Stock MarketDetailed Quotes

IMAB I-Mab

Watchlist
  • 1.770
  • -0.050-2.75%
Close Jun 18 16:00 ET
  • 1.770
  • 0.0000.00%
Post 16:08 ET
143.16MMarket Cap-728P/E (TTM)

About I-Mab Company

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.

Company Profile

SymbolIMAB
Company NameI-Mab
Listing DateJan 17, 2020
Issue Price14.00
Founded2016
CEOMr. Rajkumar Kannan
MarketNASDAQ
Employees220
Securities TypeDR
ADS Ratio10.0 : 23.0
Fiscal Year Ends12-31
Address2440 Research Boulevard,Suite 400
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-745-6330
Websitehttp://www.i-mabbiopharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Rajkumar Kannan
  • Chief Executive Officer and Director
  • --
  • Joseph Skelton
  • Chief Financial Officer
  • --
  • Dr. Phillip Dennis, M.D.
  • Chief Medical Officer
  • --
  • Dr. Pamela M. Klein, M.D.
  • Interim Chairman of the Board
  • --
  • Wei Fu
  • Director
  • --
  • Shuai Chen
  • Independent Director
  • --
  • Chun Kwok Alan Au
  • Independent Director
  • --
  • Dr. Rong Shao, PhD
  • Independent Director
  • --
  • Chia-hung Conor Yang
  • Independent Director
  • --
  • Dr. Ruyi He, M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg